Daratumumab and lenalidomide for frail patients with newly diagnosed multiple myeloma shows prom...
Автор: ecancer
Загружено: 2025-02-06
Просмотров: 107
Описание: A phase 3 trial focuses on frail elderly patients newly diagnosed with multiple myeloma, comparing daratumumab lenalidomide to standard care. The trial shows significant benefits in progression-free survival and overall survival for the daratumumab group, with participants averaging 81 years old. The safety profile indicates manageable side effects and no increase in treatment discontinuation, highlighting the importance of tailored treatment strategies for elderly patients.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: